Compound targets metabolic changes found in tumors

Cornerstone Pharmaceuticals working towards a major advancement in cancer treatment

Robert Shorr, Ph.D, D.I.C, Chief Executive Officer of Cornerstone Pharmaceuticals, talks about his company